ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death

Autophagy

Volumn 9, Issue 9, 2013, Pages 1292-1307

  Garg, Abhishek D ^a   Dudek, Aleksandra M ^a   Ferreira, Gabriela B ^b   Verfaillie, Tom ^a   Vandenabeele, Peter ^c,d   Krysko, Dmitri V ^c,d   Mathieu, Chantal ^b   Agostinis, Patrizia ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^d GHENT UNIVERSITY   (Belgium)

Author keywords

ATP; Autophagy; Calreticulin; Cancer; Dendritic cells; Immunogenic cell death; Photodynamic therapy (PDT); T cells

Indexed keywords

ADENOSINE TRIPHOSPHATE; HISTIDINE; HYPERICIN; PHOSPHOLIPID HYDROPEROXIDE GLUTATHIONE PEROXIDASE; REACTIVE OXYGEN METABOLITE;

ARTICLE; AUTOPHAGY; CANCER CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL MATURATION; DENDRITIC CELL; ENDOPLASMIC RETICULUM STRESS; ENZYME RELEASE; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOGENICITY; OXIDATIVE STRESS; PHOTODYNAMIC THERAPY;

ATP; AUTOPHAGY; CALRETICULIN; CANCER; DENDRITIC CELLS; IMMUNOGENIC CELL DEATH; PHOTODYNAMIC THERAPY (PDT); T CELLS;

ADENOSINE TRIPHOSPHATE; AUTOPHAGY; CALRETICULIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TUMOR; CELL PROLIFERATION; DENDRITIC CELLS; GENE KNOCKDOWN TECHNIQUES; GLUTATHIONE PEROXIDASE; HISTIDINE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-6; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, BIOLOGICAL; NEOPLASMS; OXIDATION-REDUCTION; PERYLENE; PHENOTYPE; PHOTOCHEMOTHERAPY; REACTIVE OXYGEN SPECIES;

EID: 84879783969     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.25399     Document Type: Article

References (63)

1. Garg AD, Bose M, Ahmed MI, Bonass WA, Wood SR. In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cells. PLoS One 2012; 7:e34475; PMID:22485174; http://dx.doi.org/10. 1371/journal.pone.0034475
2. Garg AD, Martin S, Golab J, Agostinis P. Danger signalling during cancer cell death: origins, plasticity and regulation. Cell Death Differ 2013; In press; PMID:23686135; http://dx.doi.org/10.1038/cdd.2013.48
3. Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, Agostinis P. Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation. Biochim Biophys Acta 2010; 1805: 53- 71; PMID:19720113
4. Green DR, Ferguson T, Zitvogel L, Kroemer G. Immunogenic and tolerogenic cell death. Nat Rev Immunol 2009; 9: 353-63; PMID:19365408; http://dx.doi.org/ 10.1038/nri2545
5. Zitvogel L, Kepp O, Kroemer G. Decoding cell death signals in inflammation and immunity. Cell 2010; 140: 798-804; PMID:20303871; http://dx.doi.org/10.1016/j.cell.2010.02.015
6. Casares N, Pequignot MO, Tesniere A, Ghiringhelli F, Roux S, Chaput N, et al. Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med 2005; 202: 1691-701; PMID:16365148; http://dx.doi.org/10.1084/jem. 20050915 (Pubitemid 41815875)
7. Obeid M, Tesniere A, Ghiringhelli F, Fimia GM, Apetoh L, Perfettini JL, et al. Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med 2007; 13: 54-61; PMID:17187072; http://dx.doi.org/10.1038/nm1523 (Pubitemid 46067386)
8. Krysko DV, Garg AD, Kaczmarek A, Krysko O, Agostinis P, Vandenabeele P. Immunogenic cell death and DAMPs in cancer therapy. Nat Rev Cancer 2012; 12: 860-75; PMID:23151605; http://dx.doi.org/10.1038/nrc3380
9. Garg AD, Krysko DV, Verfaillie T, Kaczmarek A, Ferreira GB, Marysael T, et al. A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death. EMBO J 2012; 31: 1062-79; PMID:22252128; http://dx.doi.org/10.1038/emboj.2011.497
10. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin. Cancer Immunol Immunother 2012; 61: 215-21; PMID:22193987; http://dx.doi.org/10.1007/s00262-011-1184-2
11. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, et al. Activation of the NLRP3 inflammasome in dendritic cells induces IL-1betadependent adaptive immunity against tumors. Nat Med 2009; 15: 1170-8; PMID:19767732; http://dx.doi.org/10.1038/nm.2028
12. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med 1995; 182: 1545-56; PMID:7595224; http://dx.doi.org/10.1084/jem.182.5.1545
13. Michaud M, Martins I, Sukkurwala AQ, Adjemian S, Ma Y, Pellegatti P, et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334: 1573-7; PMID:22174255; http://dx.doi.org/10. 1126/science.1208347
14. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochem Photobiol Sci 2011; 10: 670-80; PMID:21258717; http://dx.doi.org/10.1039/c0pp00294a
15. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, et al. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med 2007; 13: 1050-9; PMID:17704786; http://dx.doi.org/10.1038/nm1622 (Pubitemid 47517504)
16. Galluzzi L, Kepp O, Kroemer G. Enlightening the impact of immunogenic cell death in photodynamic cancer therapy. EMBO J 2012; 31: 1055-7; PMID:22252132; http://dx.doi.org/10.1038/emboj.2012.2
17. Garg AD, Krysko DV, Vandenabeele P, Agostinis P. The emergence of phox-ER stress induced immunogenic apoptosis. Oncoimmunology 2012; 1: 786-8; PMID:22934283; http://dx.doi.org/10.4161/onci.19750
18. Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, et al. Molecular characteristics of immunogenic cancer cell death. Cell Death Differ 2008; 15: 3-12; PMID:18007663; http://dx.doi.org/10.1038/sj.cdd.4402269 (Pubitemid 350286167)
19. Dudek AM, Garg AD, Krysko DV, De Ruysscher D, Agostinis P. Inducers of immunogenic cancer cell death. Cytokine Growth Factor Rev 2013; In press; PMID:23391812; http://dx.doi.org/10.1016/j. cytogfr.2013.01.005
20. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, et al. Photodynamic therapy of cancer: an update. CA Cancer J Clin 2011; 61: 250- 81; PMID:21617154; http://dx.doi.org/10.3322/caac.20114
21. Garg AD, Nowis D, Golab J, Agostinis P. Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity. Apoptosis 2010; 15: 1050-71; PMID:20221698; http://dx.doi.org/10.1007/s10495-010-0479-7
22. Verfaillie T, Rubio N, Garg AD, Bultynck G, Rizzuto R, Decuypere JP, et al. PERK is required at the ER-mitochondrial contact sites to convey apoptosis after ROS-based ER stress. Cell Death Differ 2012; 19: 1880-91; PMID:22705852; http://dx.doi.org/10.1038/cdd.2012.74
23. Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, et al. Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 2006; 20: 756-8; PMID:16455754 (Pubitemid 46671205)
24. Verfaillie T, Garg AD, Agostinis P. Targeting ER stress induced apoptosis and inflammation in cancer. Cancer Lett 2013; 332: 249-64; PMID:20732741; http://dx.doi.org/10.1016/j.canlet.2010.07.016
25. Buytaert E, Matroule JY, Durinck S, Close P, Kocanova S, Vandenheede JR, et al. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells. Oncogene 2008; 27: 1916-29; PMID:17952126; http://dx.doi.org/10.1038/sj.onc.1210825 (Pubitemid 351430819)
26. Garg AD, Verfaillie T, Rubio N, Ferreira GB, Mathieu C, Agostinis P. Hypericin-PDT treatment of cancer cells leads to surface exposure/extracellular release of DAMPs and activates human immature dendritic cells. Belgian J Med Oncol 2010; 4: 93-4
27. Pearce EL. Metabolism in T cell activation and differentiation. Curr Opin Immunol 2010; 22: 314- 20; PMID:20189791; http://dx.doi.org/10.1016/j.coi.2010. 01.018
28. Cantor JM, Ginsberg MH. CD98 at the crossroads of adaptive immunity and cancer. J Cell Sci 2012; 125: 1373-82; PMID:22499670; http://dx.doi.org/10.1242/ jcs.096040
29. Ly LV, Sluijter M, Versluis M, Luyten GP, van Stipdonk MJ, van der Burg SH, et al. Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm. Cancer Res 2010; 70: 8339-46; PMID:20940397; http://dx.doi.org/10.1158/0008- 5472.CAN-10-2288
30. Ferradini L, Mackensen A, Genevée C, Bosq J, Duvillard P, Avril MF, et al. Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion. J Clin Invest 1993; 91: 1183- 90; PMID:8450047; http://dx.doi.org/ 10.1172/JCI116278 (Pubitemid 23095297)
31. Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 2003; 9: 1269-74; PMID:14502282; http://dx.doi.org/10.1038/nm934 (Pubitemid 37279849)
32. Maes H, Rubio N, Garg AD, Agostinis P. Autophagy: shaping the tumor microenvironment and therapeutic response. Trends Mol Med 2013; In press; PMID:23714574; http://dx.doi.org/10.1016/j.molmed.2013.04.005
33. Dewaele M, Martinet W, Rubio N, Verfaillie T, de Witte PA, Piette J, et al. Autophagy pathways activated in response to PDT contribute to cell resistance against ROS damage. J Cell Mol Med 2011; 15: 1402-14; PMID:20626525; http://dx.doi.org/10.1111/j.1582-4934.2010.01118.x
34. Rubio N, Coupienne I, Di Valentin E, Heirman I, Grooten J, Piette J, et al. Spatiotemporal autophagic degradation of oxidatively damaged organelles after photodynamic stress is amplified by mitochondrial reactive oxygen species. Autophagy 2012; 8: 1312- 24; PMID:22889744; http://dx.doi.org/10.4161/auto. 20763
35. Panaretakis T, Kepp O, Brockmeier U, Tesniere A, Bjorklund AC, Chapman DC, et al. Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J 2009; 28: 578- 90; PMID:19165151; http://dx.doi.org/10.1038/ emboj.2009.1
36. Johnson S, Michalak M, Opas M, Eggleton P. The ins and outs of calreticulin: from the ER lumen to the extracellular space. Trends Cell Biol 2001; 11: 122- 9; PMID:11306273; http://dx.doi.org/10.1016/S0962-8924(01)01926-2 (Pubitemid 32289442)
37. Papp S, Opas M. Sub-Cellular Distribution of Calreticulin. In: Eggleton P, Michalak M, eds. Calreticulin. Georgetown, Tex.; New York, N.Y.: Landes Bioscience/Eurekah.com; Kluwer Academic/Plenum, 2003: 38-48
38. Xiao G, Chung TF, Pyun HY, Fine RE, Johnson RJ. KDEL proteins are found on the surface of NG108- 15 cells. Brain Res Mol Brain Res 1999; 72: 121- 8; PMID:10529470; http://dx.doi.org/10.1016/S0169-328X(99)00188-6 (Pubitemid 29472397)
39. Bravo R, Vicencio JM, Parra V, Troncoso R, Munoz JP, Bui M, et al. Increased ER-mitochondrial coupling promotes mitochondrial respiration and bioenergetics during early phases of ER stress. J Cell Sci 2011; 124: 2143-52; PMID:21628424; http://dx.doi.org/10.1242/jcs.080762
40. Kühn H, Borchert A. Regulation of enzymatic lipid peroxidation: the interplay of peroxidizing and peroxide reducing enzymes. Free Radic Biol Med 2002; 33: 154-72; PMID:12106812 (Pubitemid 34775188)
41. Klionsky DJ, Abdalla FC, Abeliovich H, Abraham RT, Acevedo-Arozena A, Adeli K, et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012; 8: 445- 544; PMID:22966490; http://dx.doi.org/10.4161/auto.19496
42. Menger L, Vacchelli E, Adjemian S, Martins I, Ma Y, Shen S, et al. Cardiac glycosides exert anticancer effects by inducing immunogenic cell death. Sci Transl Med 2012; 4: 43ra99; PMID:22814852; http://dx.doi.org/10.1126/ scitranslmed.3003807
43. Peters LR, Raghavan M. Endoplasmic reticulum calcium depletion impacts chaperone secretion, innate immunity, and phagocytic uptake of cells. J Immunol 2011; 187: 919-31; PMID:21670312; http://dx.doi.org/10.4049/jimmunol.1100690
44. Tarr JM, Young PJ, Morse R, Shaw DJ, Haigh R, Petrov PG, et al. A mechanism of release of calreticulin from cells during apoptosis. J Mol Biol 2010; 401: 799-812; PMID:20624402; http://dx.doi.org/10.1016/j.jmb.2010.06.064
45. Tufi R, Panaretakis T, Bianchi K, Criollo A, Fazi B, Di Sano F, et al. Reduction of endoplasmic reticulum Ca2+ levels favors plasma membrane surface exposure of calreticulin. Cell Death Differ 2008; 15: 274- 82; PMID:18034188; http://dx.doi.org/10.1038/sj.cdd.4402275
46. Yorimitsu T, Nair U, Yang Z, Klionsky DJ. Endoplasmic reticulum stress triggers autophagy. J Biol Chem 2006; 281: 30299-304; PMID:16901900; http://dx.doi.org/10.1074/jbc.M607007200 (Pubitemid 44537037)
47. Nyström T. Role of oxidative carbonylation in protein quality control and senescence. EMBO J 2005; 24: 1311-7; PMID:15775985; http://dx.doi.org/10.1038/sj.emboj.7600599 (Pubitemid 40593052)
48. Kaushik S, Massey AC, Mizushima N, Cuervo AM. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol Biol Cell 2008; 19: 2179-92; PMID:18337468; http://dx.doi.org/10.1091/mbc.E07-11-1155
49. Pyo JO, Nah J, Kim HJ, Lee HJ, Heo J, Lee H, et al. Compensatory activation of ERK1/2 in Atg5- deficient mouse embryo fibroblasts suppresses oxidative stress-induced cell death. Autophagy 2008; 4: 315-21; PMID:18196969 (Pubitemid 351458092)
50. Garg AD, Kaczmarek A, Krysko O, Vandenabeele P, Krysko DV, Agostinis P. ER stress-induced inflammation: does it aid or impede disease progression? Trends Mol Med 2012; 18: 589-98; PMID:22883813; http://dx.doi.org/10.1016/j. molmed.2012.06.010
51. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004; 75: 163-89; PMID:14525967; http://dx.doi.org/10.1189/jlb.0603252 (Pubitemid 38174573)
52. Zaidi MR, Merlino G. The two faces of interferon-γ in cancer. Clin Cancer Res 2011; 17: 6118-24; PMID:21705455; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0482
53. Matarese G, La Cava A, Horvath TL. In vivo veritas, in vitro artificia. Trends Mol Med 2012; 18: 439- 42; PMID:22682514; http://dx.doi.org/10.1016/j. molmed.2012.05.003
54. Martins I, Tesniere A, Kepp O, Michaud M, Schlemmer F, Senovilla L, et al. Chemotherapy induces ATP release from tumor cells. Cell Cycle 2009; 8: 3723-8; PMID:19855167; http://dx.doi.org/10.4161/cc.8.22.10026
55. Thorburn J, Horita H, Redzic J, Hansen K, Frankel AE, Thorburn A. Autophagy regulates selective HMGB1 release in tumor cells that are destined to die. Cell Death Differ 2009; 16: 175- 83; PMID:18846108; http://dx.doi.org/10. 1038/cdd.2008.143
56. Kazama H, Ricci JE, Herndon JM, Hoppe G, Green DR, Ferguson TA. Induction of immunological tolerance by apoptotic cells requires caspasedependent oxidation of high-mobility group box-1 protein. Immunity 2008; 29: 21-32; PMID:18631454; http://dx.doi.org/10.1016/j.immuni.2008.05.013 (Pubitemid 351952462)
57. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012; 209: 1519-28; PMID:22869893; http://dx.doi.org/10.1084/jem.20120189
58. Kharbanda S, Garg AD. F1000 Recommendation of [Venereau E et al., J Exp Med 2012, 209: 1519-28]. Faculty of 1000 2012; f1000.com/717953753#eval793459358
59. Wei H, Wei S, Gan B, Peng X, Zou W, Guan JL. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 2011; 25: 1510- 27; PMID:21764854; http://dx.doi.org/10.1101/gad.2051011
60. Noman MZ, Janji B, Kaminska B, Van Moer K, Pierson S, Przanowski P, et al. Blocking hypoxiainduced autophagy in tumors restores cytotoxic T-cell activity and promotes regression. Cancer Res 2011; 71: 5976-86; PMID:21810913; http://dx.doi.org/10.1158/0008-5472.CAN-11-1094
61. Ferreira GB, van Etten E, Lage K, Hansen DA, Moreau Y, Workman CT, et al. Proteome analysis demonstrates profound alterations in human dendritic cell nature by TX527, an analogue of vitamin D. Proteomics 2009; 9: 3752-64; PMID:19639594; http://dx.doi.org/10.1002/pmic.200800848
62. Mohanty JG, Bhamidipaty S, Evans MK, Rifkind JM. A fluorimetric semi-microplate format assay of protein carbonyls in blood plasma. Anal Biochem 2010; 400: 289-94; PMID:20122892; http://dx.doi.org/10.1016/j.ab.2010.01.032
63. Vantieghem A, Assefa Z, Vandenabeele P, Declercq W, Courtois S, Vandenheede JR, et al. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett 1998; 440: 19- 24; PMID:9862416; http://dx.doi.org/10.1016/S0014-5793(98)01416-1 (Pubitemid 28558726)